GGrantIndex
Sort

1,049,261 grants matching t cell

Genomic regulation of immune response in neurodegeneration in mice

$2,520,048
Han-Yu Shih · National Eye Institute · ZIA · FY2025 · EY

Expanding Excellence in Developmental Biology in Oklahoma

$2,520,000
Linda F. Thompson · Oklahoma Medical Research Foundation · P20 · FY2016 · GM

Development of Immunogenicity- and Efficacy-Optimized CMV Vectors for an HIV/AIDS Vaccine

$2,520,000
Louis J. Picker · Oregon Health & Science University · U19 · FY2017 · AI

Expanding Excellence in Developmental Biology in Oklahoma

$2,520,000
Linda F. Thompson · Oklahoma Medical Research Foundation · P20 · FY2017 · GM

Recreating Kidney Organogenesis in vitro with Human Pluripotent Stem Cells

$2,520,000
Ryuji Morizane · Massachusetts General Hospital · DP2 · FY2019 · DK

Expanding Excellence in Developmental Biology in Oklahoma

$2,520,000
Linda F. Thompson · Oklahoma Medical Research Foundation · P20 · FY2014 · GM

TARGETING REGULATORY T CELLS TO TREAT CHRONIC MIGRAINE AND POST-TRAUMATIC HEADACHE

$2,520,000
Washington University, The · · FY2021 · Defense Health Agency

Dissection of in situ myeloid signaling using image-guided synthetic control

$2,520,000
Miles A Miller · Massachusetts General Hospital · DP2 · FY2020 · CA

Deciphering the Achilles Heel of Cancer Immunotherapy

$2,520,000
Alexandra-Chloe Villani · Massachusetts General Hospital · DP2 · FY2019 · CA

Expanding Excellence in Developmental Biology in Oklahoma

$2,520,000
Linda F. Thompson · Oklahoma Medical Research Foundation · P20 · FY2015 · GM

Optical sensing of voltage, pH, and small molecules using microbial rhodopsins

$2,520,000
Adam Ezra Cohen · Harvard University · DP2 · FY2010 · OD

Precision Delivery and Imaging to Enhance Solid Tumor Therapy

$2,519,995
Jan E Schnitzer · Proteogenomics Research Instit/Sys/ Med · P01 · FY2023 · CA

Naturally-Acquired and Vaccine-Mediated Immunity to Leptospirosis

$2,519,964
Albert Icksang Ko · Yale University · R01 · FY2017 · AI

Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy

$2,519,818
Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL

S.P.O.R.E. in Prostate Cancer

$2,519,289
Kenneth J. Pienta · University Of Michigan At Ann Arbor · P50 · FY2007 · CA

Emory WIHS CRS - Longitudinal Cohort

$2,519,163
Ighovwerha Ofotokun · Emory University · U01 · FY2018 · AI

USC FaceBase III Craniofacial Development and Dysmorpholoy Data Management and Integration Hub

$2,519,134
Carl Kesselman · University Of Southern California · U01 · FY2022 · DE

Pulmonary Hypertension Breakthrough Initiative

$2,518,872
Mark W Geraci · Indiana University Indianapolis · R24 · FY2016 · HL

NEDD9 and Chromium(VI) Carcinogenesis

$2,518,755
Max Costa · New York University School Of Medicine · R01 · FY2025 · ES

Adoptive Cell Transfer Immunotherapy of Cancer

$2,518,659
Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Gene therapy of cancer

$2,518,659
Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Scale up single-cell technologies to map pain-associated genes and cells across the lifespan

$2,518,511
Jian Shu · Massachusetts General Hospital · DP2 · FY2022 · TR

A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?

$2,518,214
Christopher K Glass · University Of California, San Diego · P01 · FY2022 · HL

Genomic and Computational Biology Support for NIDCD Intramural Research

$2,517,962
Robert J Morell · National Institute On Deafness And Other Communication Disorders · ZIC · FY2019 · DC

Regulation of BRCA-dependent Genome Repair via the 53BP1 Axis

$2,517,723
Patrick Sung · University Of Texas Hlth Science Center · P01 · FY2025 · CA